首页> 外文期刊>Journal of Zhejiang University. Science, B >Secondary sentinel lymph node tracing technique: a new method for tracing lymph nodes in radical gastrectomy for advanced gastric cancer
【24h】

Secondary sentinel lymph node tracing technique: a new method for tracing lymph nodes in radical gastrectomy for advanced gastric cancer

机译:次级哨兵淋巴结跟踪技术:一种新方法,用于治疗晚期胃癌的根治胃切除术中淋巴结

获取原文
       

摘要

Objective: To explore the feasibility and clinical value of secondary sentinel lymph node (SSLN) tracing technique in radical gastrectomy for advanced gastric cancer (AGC). Methods: From January 2009 to June 2011, 247 patients who suffered from gastric angle cancer with metastasis in No. 3 group lymph nodes were divided randomly into groups A and B. Methylthioninium chloride was injected into the peripheral tissue of the metastatic No. 3 group lymph nodes of 138 patients in group A before tumor resections. SSLNs were traced and individual lymphadenectomies were carried out based on the biopsy results of the SSLNs. Standard D2 radical gastrectomies were carried out directly on 109 patients in group B. Postoperative follow-up and survival analysis were carried out for patients in both groups. Results: SSLNs were found in 114 (82.6%) patients in group A. Ninety of those patients (78.9%) demonstrated existing metastasis in SSLNs. According to Kaplan-Meier’s method, the postoperative 3-year cumulative survival rates were 63.5% and 47.5%, and the median survival time were 40 and 36 months for the patients of groups A and B, respectively (P<0.05). Conclusions: The SSLN tracing technique is feasible in radical gastrectomy for AGC. It gives surgeons important information about the terminal status of lymph node metastasis and provides some scientific basis for individual lymphadenectomy.
机译:目的:探讨次级哨兵淋巴结(SSLN)追踪技术在激进胃癌直肠胃癌(AGC)中的可行性和临床价值。方法:2009年1月至2011年6月,347名患有在第3组淋巴结中胃角癌的胃角癌的患者随机分为A组和B.将甲硫氨基硫氨酸注射到转移号3组的周围组织中138例肿瘤切除前138名患者的淋巴结。 SSLNS被追踪,基于SSLN的活检结果进行单独的淋巴结切除术。标准D2自由基胃切除术直接在B组109例患者中进行。术后随访和存活分析在两组患者中进行。结果:SSLNS于114名(82.6%)患者中发现,其中九十名患者(78.9%)在SSLNS中显示出现有的转移。根据Kaplan-Meier的方法,术后3年的累积存活率为63.5%和47.5%,分别为A和B组患者的中位生存时间为40和36个月(P <0.05)。结论:SSLN跟踪技术在AGC的激进胃切除术中是可行的。它为外科医生提供有关淋巴结转移的末端状态的重要信息,并为个体淋巴结切除术提供一些科学依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号